Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $40.26 $52.54 Friday, 10th May 2024 RARE stock ended at $40.90. This is 0.776% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.23% from a day low at $40.26 to a day high of $41.56.
90 days $40.26 $54.55
52 weeks $31.52 $54.98

Historical Ultragenyx Pharmaceutical Inc. prices

Date Open High Low Close Volume
Aug 30, 2023 $36.26 $36.96 $36.15 $36.56 440 355
Aug 29, 2023 $36.51 $37.31 $36.32 $36.57 475 515
Aug 28, 2023 $38.01 $38.81 $36.25 $36.68 466 113
Aug 25, 2023 $36.97 $38.57 $36.97 $37.91 405 644
Aug 24, 2023 $36.71 $37.23 $35.94 $36.97 569 520
Aug 23, 2023 $36.06 $36.81 $36.06 $36.60 388 892
Aug 22, 2023 $36.99 $37.34 $35.98 $36.08 390 438
Aug 21, 2023 $34.81 $37.22 $34.81 $36.97 911 785
Aug 18, 2023 $34.88 $35.52 $34.33 $35.09 576 116
Aug 17, 2023 $37.11 $37.15 $34.88 $34.92 477 290
Aug 16, 2023 $38.39 $38.65 $36.89 $37.12 474 780
Aug 15, 2023 $37.94 $38.41 $37.31 $38.39 389 749
Aug 14, 2023 $36.12 $37.92 $35.80 $37.90 487 972
Aug 11, 2023 $36.48 $36.68 $36.02 $36.32 447 314
Aug 10, 2023 $36.86 $37.36 $36.36 $36.52 467 513
Aug 09, 2023 $35.28 $36.92 $35.27 $36.83 733 863
Aug 08, 2023 $35.96 $36.86 $35.06 $35.19 732 237
Aug 07, 2023 $37.43 $38.55 $35.94 $36.14 852 980
Aug 04, 2023 $41.09 $41.28 $37.50 $37.67 1 638 480
Aug 03, 2023 $42.35 $42.71 $41.28 $41.30 510 979
Aug 02, 2023 $42.59 $42.69 $41.70 $42.35 434 266
Aug 01, 2023 $42.93 $43.27 $42.43 $42.92 308 743
Jul 31, 2023 $43.46 $44.28 $42.92 $43.12 349 493
Jul 28, 2023 $42.37 $43.66 $41.44 $43.11 369 987
Jul 27, 2023 $42.34 $42.34 $41.42 $41.99 309 607
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT